CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award | +8,746 | 2,719,343 | ||
| 2023-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +52,472 | 52,472 | ||
| 2023-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +52,472 | 52,472 | ||
| 2023-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +990 | 12,705 | ||
| 2023-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −291 | $11.15 | $3K | 12,414 |
| 2023-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | +990 | 1,981 | ||
| 2023-04-10 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +3,933 | 14,132 | ||
| 2023-04-10 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −1,155 | $10.71 | $12K | 12,977 |
| 2023-04-10 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | +3,933 | 11,797 | ||
| 2023-04-10 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise | +2,477 | 13,906 | ||
| 2023-04-10 | Moat Ross CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −1,353 | $10.71 | $14K | 12,553 |
| 2023-04-10 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Share Unit | +2,477 | 7,431 | ||
| 2023-04-10 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +2,498 | 42,644 | ||
| 2023-04-10 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −734 | $10.71 | $8K | 41,910 |
| 2023-04-10 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | +2,498 | 7,492 | ||
| 2023-04-10 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +9,992 | 45,507 | ||
| 2023-04-10 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −2,933 | $10.71 | $31K | 42,574 |
| 2023-04-10 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | +9,992 | 29,975 | ||
| 2023-04-10 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +2,695 | 12,506 | ||
| 2023-04-10 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −791 | $10.71 | $8K | 11,715 |
Page 61 of 74 · 1,467 trades